The pathogenesis of Graves' orbitopathy (GO) is not completely understood. Coexistent hyperfunction of the thyroid gland is frequent; however, GO may also coexist with hypo- or euthyrodism. The course of GO is largely independent of thyroid function, although elevated serum TSH is known to negatively interfere with GO course. GO is severe in 10% of the cases; sight threatening complications may also develop. A successful therapy of GO requires the assesment of both the severity and activity of orbital inflammation. Based on relevant studies and our own experiences, the possible management choices are reviewed here. For this purpose, we compare the clinical value of imaging techniques for detecting the activity of the disease. During the last 15 years, we used 99mTc-DTPA retrobulbar SPECT routinely in more than 1400 patients to facilitate the right therapeutic decision. This diagnostic utility simplified management decisions compared to previously applied alternative techniques. We recommended the routine use of 99mTc-DTPA retrobulbar SPECT for the evaluation and follow-up of GO.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5603/NMR.a2018.0005 | DOI Listing |
Front Endocrinol (Lausanne)
August 2023
Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, Katowice, Poland.
The most frequent extrathyroidal Graves' disease manifestation is Graves' orbitopathy (GO). The treatment of GO is determined by its severity and activity. There is currently no reliable, impartial method for assessing it clinically or distinguishing fibrosis from active inflammatory disorders.
View Article and Find Full Text PDFNucl Med Rev Cent East Eur
September 2018
University of Debrecen, Nagyerdei krt 98, 4032 Debrecen, Hungary.
The pathogenesis of Graves' orbitopathy (GO) is not completely understood. Coexistent hyperfunction of the thyroid gland is frequent; however, GO may also coexist with hypo- or euthyrodism. The course of GO is largely independent of thyroid function, although elevated serum TSH is known to negatively interfere with GO course.
View Article and Find Full Text PDFNucl Med Commun
February 2013
Department of Nuclear Medicine, Medical and Health Science Center, University of Debrecen, Nagyerdei krt. 98., Debrecen H-4032, Hungary.
Objective: In Graves' ophthalmopathy (GO), there is a demand to differentiate the immunologically active disease state, when immunosuppressive therapy is necessary, from the inactive state, when the patient would not benefit from it. We measured the inflammatory activity in the retrobulbar region using Tc-diethylene triamine pentaacetic acid (DTPA) SPECT before and after external radiation to determine whether this method is suitable for predicting the effectiveness of this therapy.
Materials And Methods: Thirty-two patients with suspected active GO were involved in this retrospective study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!